Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 3:13:840293.
doi: 10.3389/fphys.2022.840293. eCollection 2022.

Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis

Affiliations
Review

Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis

Keda Yang et al. Front Physiol. .

Abstract

Osteoporosis is a common bone imbalance disease that threatens the health of postmenopausal women. Estrogen deficiency accelerates the aging of women. Oxidative stress damage is regarded as the main pathogenesis of postmenopausal osteoporosis. The accumulation of reactive oxygen species in the bone microenvironment plays a role in osteoblast and osteoclast apoptosis. Improving the oxidative state is essential for the prevention and treatment of postmenopausal osteoporosis. There are three classes of antioxidant defense systems in the body to eliminate free radicals and peroxides including antioxidant substances, antioxidant enzymes, and repair enzymes. In our review, we demonstrated the mechanism of antioxidants and their effect on bone metabolism in detail. We concluded that glutathione/oxidized glutathione (GSH/GSSG) conversion involved the PI3K/Akt-Nrf2/HO-1 signaling pathway and that the antioxidant enzyme-mediated mitochondrial apoptosis pathway of osteoblasts was necessary for the development of postmenopausal osteoporosis. Since the current therapeutic effects of targeting bone cells are not significant, improving the systemic peroxidation state and then regulating bone homeostasis will be a new method for the treatment of postmenopausal osteoporosis.

Keywords: GSH/GSSG; PI3K/AKT/Nrf2/HO-1; antioxidant system; oxidative stress; postmenopausal osteoporosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The antioxidant effect of estrogen.
FIGURE 2
FIGURE 2
The mechanism of reactive oxygen species on osteoblasts and osteoclasts.
FIGURE 3
FIGURE 3
The mechanism of PLA2 on increasing osteogenesis.
FIGURE 4
FIGURE 4
The vicious circle of DNA damage and purine metabolism.
FIGURE 5
FIGURE 5
The process of antioxidant systems to eliminate free radicals.

Similar articles

Cited by

References

    1. Abdallah H. M., Farag M. A., Algandaby M. M., Nasrullah M. Z., Abdel-Naim A. B., Eid B. G., et al. (2020). Osteoprotective Activity and Metabolite Fingerprint via UPLC/MS and GC/MS of Lepidium sativum in Ovariectomized Rats. Nutrients 12:2075. 10.3390/nu12072075 - DOI - PMC - PubMed
    1. Adibhatla R. M., Hatcher J. F. (2008). Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies. BMB Rep. 41 560–567. 10.5483/bmbrep.2008.41.8.5602/18/2022 - DOI - PMC - PubMed
    1. Al E. A. A., Parsian H., Fathi M., Faghihzadeh S., Hosseini S. R., Nooreddini H. G., et al. (2018). ALOX12 gene polymorphisms and serum selenium status in elderly osteoporotic patients. Adv. Clin. Exp. Med. 27 1717–1722. 10.17219/acem/75689 - DOI - PubMed
    1. Alcendor R. R., Gao S., Zhai P., Zablocki D., Holle E., Yu X., et al. (2007). Sadoshima, Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100 1512–1521. - PubMed
    1. Ameen O., Yassien R. I., Naguib Y. M. (2020). Activation of FoxO1/SIRT1/RANKL/OPG pathway may underlie the therapeutic effects of resveratrol on aging-dependent male osteoporosis. BMC Musculoskelet. Disord. 21:375. 10.1186/s12891-020-03389-w - DOI - PMC - PubMed

LinkOut - more resources